Literature DB >> 6231286

Controlled proteolysis of the purified Ca2+-ATPase of the erythrocyte membrane. A correlation between the structure and the function of the enzyme.

M Zurini, J Krebs, J T Penniston, E Carafoli.   

Abstract

The purified Ca2+-pumping ATPase of the erythrocyte plasma membrane has been subjected to a controlled proteolytic treatment with trypsin. The treatment has been previously shown to shift the enzyme from low to high Ca2+ affinity in the absence of calmodulin. The treatment leads to the fragmentation of the ATPase molecule into a number of products and to the accumulation of major limit polypeptides having Mr of 14,000, 28,000, 33,500, 48,000, and 76,000. The 33,500 Mr fragment reacts with 3(trifluoromethyl)-3 (m-[125I]iodophenyl)-diazirine, suggesting that it contains intramembrane regions of the enzyme. A number of minor fragmentation products were also formed, among them a polypeptide of Mr = 90,000 which is rapidly degraded further and a limit polypeptide of Mr about 25,000. [125I]Iodoazidocalmodulin cross-linked only to the original ATPase and to the fragments with Mr = 90,000 and Mr about 25,000. The Mr = 90,000 fragment can be isolated on calmodulin-Sepharose and on phenothiazine affinity columns. It retains the functional properties of the intact pump; it has a calmodulin-responsive ATPase activity and it actively accumulates Ca2+ upon incorporation into liposomes. Further proteolysis of the Mr = 90,000 fragment produces a fragment of Mr = 81,000-76,000 which forms an acylphosphate intermediate, which does not bind to calmodulin-Sepharose, and which seems to be responsible for the calmodulin-insensitive activity which appears as it is produced. A model is presented which postulates a major and a minor degradation pattern and rationalizes the pattern of proteolysis and of the [125I]iodoazidocalmodulin binding observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231286

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme.

Authors:  R Falchetto; T Vorherr; E Carafoli
Journal:  Protein Sci       Date:  1992-12       Impact factor: 6.725

2.  Cellular and segmental distribution of Ca2(+)-pump epitopes in rat intestine.

Authors:  J L Borke; A Caride; A K Verma; J T Penniston; R Kumar
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

3.  Structure--function relationship of the human erythrocyte plasma membrane Ca(2+)-ATPase revealed by V8 protease treatment.

Authors:  K K Wang; B D Roufogalis; T H Kuo
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

4.  Ca2+ transport activities of inside-out vesicles prepared from density-separated erythrocytes from rat and human.

Authors:  N W Seidler; N I Swislocki
Journal:  Mol Cell Biochem       Date:  1991-07-10       Impact factor: 3.396

Review 5.  Recent advances in the molecular characterization of plasma membrane Ca2+ pumps.

Authors:  E E Strehler
Journal:  J Membr Biol       Date:  1991-02       Impact factor: 1.843

Review 6.  Subunit assembly and functional maturation of Na,K-ATPase.

Authors:  K Geering
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

Review 7.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

8.  Evidence for the presence in smooth muscle of two types of Ca2+-transport ATPase.

Authors:  F Wuytack; L Raeymaekers; J Verbist; H De Smedt; R Casteels
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

9.  Effects of affinity-purified antibodies on the Ca2+ pumping ATPase of erythrocyte membranes.

Authors:  A K Verma; J T Penniston; S Muallem; V Lew
Journal:  J Bioenerg Biomembr       Date:  1984-12       Impact factor: 2.945

10.  A C-terminal, calmodulin-like regulatory domain from the plasma membrane Ca2+-pumping ATPase.

Authors:  P Brandt; M Zurini; R L Neve; R E Rhoads; T C Vanaman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.